Roche’s Alecensa®

• Government
• Healthcare
• Pharma & Biotech
• Switzerland

US FDA grants accelerated approval to Roche’s Alecensa® for the treatment of people with specific type of lung cancer

BASEL, 14-12-2015 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) granted…